Knight Capital Group Resumes Selling (PSTI, HCA, TSN, KCG)

Knight Capital Group Inc. (NYSE:KCG) is set to enter into a $400 million financing deal with a group of investors. An announcement on the deal is expected by early on August 06, 2012. The capital lifeline is coming from investors that include private equity firm Blackstone Group, Chicago market-maker Getco in which private equity firm General Atlantic is a shareholder - as well as financial services firms TD Ameritrade Stifel Nicolas Jefferies Group Inc and Stephens Inc. The investment is expected to be made through convertible preferred stock, which will have a conversion price of $1.50 per share and carry a coupon of 2%. Shares of KCG slumped 25% to $3.04 aftyer soaring 58% in the prior trading session. The stock has lost 70% since last Wednesday.

Can KCG Recover Soon? Get Our Special Report

Pluristem Therapeutics Inc. (NASDAQ:PSTI) stock soared 21.45% to $4.03 in the pre-market hour after the company today said that it has saved the life of a second patient with aplastic bone marrow, a condition in which the patient's bone marrow doesn't produce new blood cells. Pluristem has applied for orphan drug status from the U.S. Food and Drug Administration for its treatment, based on stem cells derived from placenta.

Should Investors Hold PSTI Now? Know More Here

HCA Holdings Inc (NYSE:HCA) stock gained 2.26% to $27.20 in the pre-market hour after the company posted second-quarter net income of $391 million or $0.85 per share, up from $229 million or $0.43 per share, in the year ago period. Adjusted net income rose to $0.85 per share from $0.51 per share in the same quarter last year. Revenue increased to $8.112 billion, from $7.249 billion in the same quarter last year. Analysts expected the company to report earnings of $0.78 per share on revenue estimate of $8.83 billion for the quarter.

Get Free Trend Analysis on HCA

Tyson Foods, Inc. (NYSE:TSN) shares fell 1.30% to $15.20 in pre-market hour after the company posted a third quarter profit of $76 million, or $0.21 a share, from $ 196 million, or $0.51 a share, a year earlier. Adjusted earnings were $0.50 a share. Revenue increased 0.7% to $8.31 billion. Analysts most recently projected earnings of $0.54 a share on revenue of $8.72 billion. Gross margin rose to 6.8% from 6.4%.